JP Morgan Chase
ROIV icon

JP Morgan Chase’s Roivant Sciences ROIV Stock Holding History

JP Morgan Chase’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.08M Hold
78,900
– – ﹤0.01% 4072
2025
Q4 		$1.71M Sell
78,900
-5,000
-6% -$98.6K ﹤0.01% 4204
2025
Q3 		$1.27M Buy
+83,900
New +$1.04M ﹤0.01% 4415
2023
Q4 		– Sell
-200,000
Closed -$2.34M – 7825
2023
Q3 		$2.34M Buy
200,000
+158,400
+381% +$1.79M ﹤0.01% 3442
2023
Q2 		$419K Buy
+41,600
New +$372K ﹤0.01% 4597

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase's ROIV Position: Q1 2026 in Review

JP Morgan Chase increased its Roivant Sciences (ROIV) stake by 65% in Q1 2026, buying an estimated $15.5M and bringing the position to 1,537,519 shares worth $40.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1519.

JP Morgan Chase first reported a position in ROIV in Q2 2022 and has held it in 16 quarters since. 440 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • JP Morgan Chase held 1,537,519 shares of Roivant Sciences worth $40.6M as of Q1 2026.
  • JP Morgan Chase bought 602,986 Roivant Sciences shares in Q1 2026, an estimated $15.5M.
  • Roivant Sciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #1519 holding.
  • JP Morgan Chase first reported a position in Roivant Sciences in Q2 2022 and has held it in 16 quarters since.
  • 440 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.